Skip to content

Study on the pathogenesis and efficacy mechanism of bullous pemphigoid based on multi-omics

Study on the pathogenesis and efficacy mechanism of bullous pemphigoid based on multi-omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105399
Enrollment
Unknown
Registered
2025-07-02
Start date
2025-07-05
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bullous pemphigoid

Interventions

Healthy control group:None
Bullous pemphigoid group:None

Sponsors

The Second Affiliated Hospital of Xi’an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Case group: 1. There is no limit to age or gender; 2. Diagnosed with bullous pemphigoid; 3. Those who voluntarily participate in the project and can implement it as required; 4. Those who have signed the informed consent form and are able to complete it as required. Control group: 1. Healthy people or volunteers; 2. Those who have signed the informed consent form and are able to complete it as required.

Exclusion criteria

Exclusion criteria: 1.Patients with BP who also have other immune-inflammatory related diseases; 2.Patients who are unable to cooperate or adhere to treatment, with poor prognostic adherence; 3.Pregnant and lactating women; 4.Patients with a combination of other diseases deemed by the investigator to be inappropriate for the program;

Design outcomes

Primary

MeasureTime frame
BPDAI,VAS scores;Single-cell transcriptome, proteome, metabolome, gut flora sequencing;

Secondary

MeasureTime frame
Inflammatory factor and molecular marker;

Countries

China

Contacts

Public ContactBin Peng

The Second Affiliated Hospital of Xi’an Jiaotong University

pbys456@126.com+86 29 8767 9301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026